From evidence planning to reimbursement realization. HEORvia turns dossier development into an intelligent, continuously updated value-demonstration engine across 12+ global HTA agencies.
AI authoring with country templates (NICE, ICER, G-BA, HAS, CADTH, PBAC) and content reuse.
Automated surveillance, AI extraction, SLR/PRISMA support, and meta-analysis prep.
CEA, CUA, budget-impact and Markov models with sensitivity analysis.
List/net/reference pricing, reimbursement decisions, and HTA-outcome monitoring.
Claims, EHR, and registry analytics for adherence and comparative effectiveness.
Continuously updated methodology and an appraisal-outcome library by market.
AI authoring with country templates (NICE, ICER, G-BA, HAS, CADTH, PBAC) and content reuse.
Automated surveillance, AI extraction, SLR/PRISMA support, and meta-analysis prep.
CEA, CUA, budget-impact and Markov models with sensitivity analysis.
List/net/reference pricing, reimbursement decisions, and HTA-outcome monitoring.
Claims, EHR, and registry analytics for adherence and comparative effectiveness.
Continuously updated methodology and an appraisal-outcome library by market.
Agency-specific templates maintained by an in-house HTA science team, not a static library.
Shared assumptions layer keeps economic models consistent across 12 markets automatically.
Competitor reimbursement outcomes surfaced alongside your own submission status.
Full audit trail satisfies agency traceability requirements on every model version.
Natural-language questions HEORvia answers in seconds:
Book a walkthrough with the right specialist and we'll tailor it to your therapeutic area and the questions your team is asking.